The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fleischer, J.
Right arrow Articles by Petersen, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fleischer, J.
Right arrow Articles by Petersen, F.
The Journal of Immunology, 2002, 169: 770-777.
Copyright © 2002 by The American Association of Immunologists

Platelet Factor 4 Inhibits Proliferation and Cytokine Release of Activated Human T Cells1

Jens Fleischer*, Evelin Grage-Griebenow{dagger}, Brigitte Kasper*, Holger Heine*, Martin Ernst*, Ernst Brandt*, Hans-Dieter Flad* and Frank Petersen2,*

* Department of Immunology and Cell Biology, Research Center Borstel, Borstel, Germany; and {dagger} Department of Experimental Pneumology, University Hospital Bergmannsheil, Bochum, Germany

Platelet factor 4 (PF-4), a platelet-derived CXC chemokine, has been shown to induce the differentiation of monocytes into a subset of macrophages that lack the expression of HLA-DR Ag. This suggests a potential role for PF-4 in the modulation of monocyte-dependent T cell activation. Using an Ag-specific stimulation model in which T cells were cocultured with monocytes in the presence of recall Ags, we could show that under these conditions PF-4-treatment caused a strong decrease of T cell proliferation as well as of IFN-{gamma} release. However, inhibition of T cell functions such as proliferation, IL-2 release, and IL-2 mRNA production did also occur when isolated T cells were activated in the absence of monocytes with immobilized Abs directed against CD3 in combination with cross-linked anti-CD28 Abs. The effect could be reversed when low concentrations of exogenous IL-2 instead of anti-CD28 were used as a costimulus in combination with anti-CD3 Abs. Further evidence for direct modulation of T cell function by PF-4 was obtained by the detection of specific binding sites for the chemokine on the surface of these cells. Taken together, our results show that specific binding of PF-4, resulting in the down-regulation of the IL-2-release correlates with the inhibition of functions in activated T cells.




This article has been cited by other articles:


Home page
J. Leukoc. Biol.Home page
N. Li
Platelet-lymphocyte cross-talk
J. Leukoc. Biol., May 1, 2008; 83(5): 1069 - 1078.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
A. Mueller, A. Meiser, E. M. McDonagh, J. M. Fox, S. J. Petit, G. Xanthou, T. J. Williams, and J. E. Pease
CXCL4-induced migration of activated T lymphocytes is mediated by the chemokine receptor CXCR3
J. Leukoc. Biol., April 1, 2008; 83(4): 875 - 882.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
G. Woller, E. Brandt, J. Mittelstadt, C. Rybakowski, and F. Petersen
Platelet factor 4/CXCL4-stimulated human monocytes induce apoptosis in endothelial cells by the release of oxygen radicals
J. Leukoc. Biol., April 1, 2008; 83(4): 936 - 945.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
D. Cervi, T.-T. Yip, N. Bhattacharya, V. N. Podust, J. Peterson, A. Abou-Slaybi, G. N. Naumov, E. Bender, N. Almog, J. E. Italiano Jr, et al.
Platelet-associated PF-4 as a biomarker of early tumor growth
Blood, February 1, 2008; 111(3): 1201 - 1207.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
B. Kasper, E. Brandt, S. Brandau, and F. Petersen
Platelet Factor 4 (CXC Chemokine Ligand 4) Differentially Regulates Respiratory Burst, Survival, and Cytokine Expression of Human Monocytes by Using Distinct Signaling Pathways
J. Immunol., August 15, 2007; 179(4): 2584 - 2591.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
L. Lasagni, R. Grepin, B. Mazzinghi, E. Lazzeri, C. Meini, C. Sagrinati, F. Liotta, F. Frosali, E. Ronconi, N. Alain-Courtois, et al.
PF-4/CXCL4 and CXCL4L1 exhibit distinct subcellular localization and a differentially regulated mechanism of secretion
Blood, May 15, 2007; 109(10): 4127 - 4134.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
B. Piqueras, J. Connolly, H. Freitas, A. K. Palucka, and J. Banchereau
Upon viral exposure, myeloid and plasmacytoid dendritic cells produce 3 waves of distinct chemokines to recruit immune effectors
Blood, April 1, 2006; 107(7): 2613 - 2618.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
B. Kasper, E. Brandt, M. Ernst, and F. Petersen
Neutrophil adhesion to endothelial cells induced by platelet factor 4 requires sequential activation of Ras, Syk, and JNK MAP kinases
Blood, March 1, 2006; 107(5): 1768 - 1775.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
R. Vermeulen, Q. Lan, L. Zhang, L. Gunn, D. McCarthy, R. L. Woodbury, M. McGuire, V. N. Podust, G. Li, N. Chatterjee, et al.
Decreased levels of CXC-chemokines in serum of benzene-exposed workers identified by array-based proteomics
PNAS, November 22, 2005; 102(47): 17041 - 17046.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
A. Schaffner, P. Rhyn, G. Schoedon, and D. J. Schaer
Regulated expression of platelet factor 4 in human monocytes--role of PARs as a quantitatively important monocyte activation pathway
J. Leukoc. Biol., July 1, 2005; 78(1): 202 - 209.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. Y. Liu, M. Battaglia, S. H. Lee, Q.-H. Sun, R. H. Aster, and G. P. Visentin
Platelet Factor 4 Differentially Modulates CD4+CD25+ (Regulatory) versus CD4+CD25- (Nonregulatory) T Cells
J. Immunol., March 1, 2005; 174(5): 2680 - 2686.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
O. Pervushina, B. Scheuerer, N. Reiling, L. Behnke, Jens.-M. Schroder, B. Kasper, E. Brandt, S. Bulfone-Paus, and F. Petersen
Platelet Factor 4/CXCL4 Induces Phagocytosis and the Generation of Reactive Oxygen Metabolites in Mononuclear Phagocytes Independently of Gi Protein Activation or Intracellular Calcium Transients
J. Immunol., August 1, 2004; 173(3): 2060 - 2067.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
C.-Q. Xia and K.-J. Kao
Effect of CXC chemokine platelet factor 4 on differentiation and function of monocyte-derived dendritic cells
Int. Immunol., August 1, 2003; 15(8): 1007 - 1015.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. Slungaard, J. A. Fernandez, J. H. Griffin, N. S. Key, J. R. Long, D. J. Piegors, and S. R. Lentz
Platelet factor 4 enhances generation of activated protein C in vitro and in vivo
Blood, July 1, 2003; 102(1): 146 - 151.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. S. V. Campanella, E. M. J. Lee, J. Sun, and A. D. Luster
CXCR3 and Heparin Binding Sites of the Chemokine IP-10 (CXCL10)
J. Biol. Chem., May 2, 2003; 278(19): 17066 - 17074.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2002 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2002 by The American Association of Immunologists, Inc. All rights reserved.